D
Dolores Vilella
Researcher at Merck & Co.
Publications - 8
Citations - 818
Dolores Vilella is an academic researcher from Merck & Co.. The author has contributed to research in topics: Farnesyl Protein Transferase & Integrase. The author has an hindex of 8, co-authored 8 publications receiving 772 citations.
Papers
More filters
Journal ArticleDOI
Discovery of a small molecule insulin mimetic with antidiabetic activity in mice.
Bei Zhang,Gino Salituro,Deborah Szalkowski,Zhihua Li,Yan Zhang,Inmaculada Royo,Dolores Vilella,Maria Teresa Diez,Fernando Pelaez,Caroline Ruby,Richard L. Kendall,Xianzhi Mao,Patrick R. Griffin,Jimmy R. Calaycay,Juleen R. Zierath,James V. Heck,Roy G. Smith,David E. Moller +17 more
TL;DR: The discovery of a nonpeptidyl fungal metabolite (L-783,281) that acted as an insulin mimetic in several biochemical and cellular assays demonstrates the feasibility of discovering novel insulin receptor activators that may lead to new therapies for diabetes.
Journal ArticleDOI
Resorcylic Acid Lactones: Naturally Occurring Potent and Selective Inhibitors of MEK
Annie Zhao,Seok H. Lee,Seok H. Lee,Marina Moiena,Rosalind G. Jenkins,Denis R. Patrick,Hans E. Huber,Michael A. Goetz,Otto D. Hensens,Deborah L. Zink,Dolores Vilella,Anne W. Dombrowski,Russell B. Lingham,Leeyuan Huang +13 more
TL;DR: A resorcylic acid lactone, L-783,277, isolated from a Phoma sp.
Journal ArticleDOI
The complestatins as HIV-1 integrase inhibitors. Efficient isolation, structure elucidation, and inhibitory activities of isocomplestatin, chloropeptin I, new complestatins, A and B, and acid-hydrolysis products of chloropeptin I.
Sheo B. Singh,Hiranthi Jayasuriya,Gino Salituro,Deborah L. Zink,Ali Shafiee,Brian Heimbuch,Keith C. Silverman,Russell B. Lingham,Olga Genilloud,Ana Teran,Dolores Vilella,Peter J. Felock,Daria J. Hazuda +12 more
TL;DR: Several new, two-step, high-yielding absorption/elution methods of isolation based on reverse-phase chromatography at pH 8 that are applicable to scales from one gram to potential industrial quantities are developed.
Journal ArticleDOI
Structure and absolute stereochemistry of HIV-1 integrase inhibitor integric acid. A novel eremophilane sesquiterpenoid produced by a Xylaria sp.
Sheo B. Singh,Deborah L. Zink,Jon D. Polishook,Delia Valentino,Ali Shafiee,Keith C. Silverman,Peter J. Felock,Ana Teran,Dolores Vilella,Daria J. Hazuda,Russell B. Lingham +10 more
TL;DR: Integric acid, a novel eremophilane sesquiterpenoid, was discovered from the screening of natural product libraries and inhibited 3′ -end processing, strand transfer and disintegration reactions catalyzed by HIV-1 integrase with IC50 values of 3–10 μM.
Journal ArticleDOI
Inhibitors of farnesylation of Ras from a microbial natural products screening program
Dolores Vilella,Manuel Sanchez,Gonzalo Platas,Oscar Salazar,Olga Genilloud,Inmaculada Royo,Carmen Cascales,Isabel Martin,T Díez,Keith C. Silverman,Russell B. Lingham,Sheo B. Singh,Hiranthi Jayasuriya,Fernando Pelaez +13 more
TL;DR: Ten different families of compounds are identified, all of which selectively inhibit FPTase with a variety of mechanisms, which originated from the fermentations of a number of microorganisms, either actinomycetes or fungi, isolated from different substrates collected in tropical and temperate areas.